BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 55,306,226 | $54,866,518 | 2.72% |
| MACKAY SHIELDS LLC | 76,286,000 | $74,883,901 | 2.06% |
| Sonora Investment Management Group, LLC | 10,890,000 | $10,840,075 | 0.93% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 39,812,000 | $39,636,827 | 0.92% |
| BANQUE PICTET & CIE SA | 636,000 | $63,228,545 | 0.75% |
| PIER 88 INVESTMENT PARTNERS LLC | 1,902,000 | $1,884,616 | 0.47% |
| LOOMIS SAYLES & CO L P | 2,074,551 | $183,557 | 0.32% |
| Liberty Mutual Group Asset Management Inc. | 1,025,000 | $1,015 | 0.28% |
| iA Global Asset Management Inc. | 14,690,000 | $14,625 | 0.24% |
| RATIONAL ADVISORS LLC | 1,803,000 | $1,786,052 | 0.16% |